Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Era7 Bioinformatics
AddedFeb 18, 2024
UpdatedJun 18, 2026
Era7 Bioinformatics

Era7 Bioinformatics

Pre-Seed

Era7 Bioinformatics: NGS project design to data analysis with custom software and cloud services.

HQ
Cambridge, MA, US
Founded
2005
Overview
Compare
Fundraising
Employees
Website

Era7 Bioinformatics, founded with a mission to advance the field of bioinformatics through innovative solutions, focuses on Next Generation Sequencing (NGS) and cloud computing. The company's core vision is to leverage revolutionary technologies to transform data analysis and project design in genomics. Era7 Bioinformatics offers a comprehensive suite of services, including custom software development and cloud-based solutions, catering to research institutions and biotech companies.

Notable figures affiliated with Era7 Bioinformatics include leading bioinformaticians and researchers who contribute to its cutting-edge projects. The company has achieved significant milestones, such as the development of proprietary products like Genbrain, which showcases their capability in producing advanced bioinformatics solutions. Era7 Bioinformatics has made a substantial impact in the genomics field by enabling more efficient and accurate data analysis, thereby accelerating scientific discoveries and advancements.

Era7 Bioinformatics - Similar Companies

Basepair logo

Basepair

basepairtech.com

Seven Bridges logo

Seven Bridges

sevenbridges.com

Watershed Informatics logo

Watershed Informatics

watershed.bio

Bioinfoexperts logo

Bioinfoexperts

bioinfox.com

BioDatomics logo

BioDatomics

biodatomics.com

BioTuring logo

BioTuring

bioturing.com

Dnanexus logo

Dnanexus

dnanexus.com

Bioinformatics logo

Bioinformatics

bioinfoinc.com

Sequegenics logo

Sequegenics

sequegenics.com

Sentieon logo

Sentieon

sentieon.com

GenomeNext logo

GenomeNext

eBioinformatics logo

eBioinformatics

InSyBio logo

InSyBio

insybio.gr

Genomenon logo

Genomenon

genomenon.com

Station X logo

Station X

Era7 Bioinformatics - Quick Facts

Who are Era7 Bioinformatics' competitors?

Companies similar to Era7 Bioinformatics include Basepair, Seven Bridges, Watershed Informatics and Bioinfoexperts.

When was Era7 Bioinformatics founded?

Era7 Bioinformatics was founded in 2005.

Where is Era7 Bioinformatics' headquarters located?

Era7 Bioinformatics' headquarters is located in Cambridge, MA, US.

When was Era7 Bioinformatics' last funding round?

Era7 Bioinformatics' most recent funding round was for $600k (USD) in January 2017.

How much has Era7 Bioinformatics raised to-date?

As of Jan 3, 2017, Era7 Bioinformatics has raised a total of $600k (USD).

How many employees does Era7 Bioinformatics have?

Era7 Bioinformatics has 30 employees as of Feb 4, 2024.

Era7 Bioinformatics - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Technology
  • Cloud Computing
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Small Business
Main Product
  • Data Analysis
Tags
  • Biotech
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software